Abstract: A semiconductor device includes: M*1st conductors in a first layer of metallization (M*1st layer) and being aligned correspondingly along different corresponding ones of alpha tracks and representing corresponding inputs of a cell region in the semiconductor device; and M*2nd conductors in a second layer of metallization (M*2nd layer) aligned correspondingly along beta tracks, and the M*2nd conductors including at least one power grid (PG) segment and one or more of an output pin or a routing segment; and each of first and second ones of the input pins having a length sufficient to accommodate at most two access points; each of the access points of the first and second input pins being aligned to a corresponding different one of first to fourth beta tracks; and the PG segment being aligned with one of the first to fourth beta tracks.

Abstract: An intraocular pressure inspection device includes an intraocular pressure detection unit, a high-precision positioning system and a wide-area positioning system, wherein according to the position of the intraocular pressure detection unit, a set of high-precision coordinates output by the high-precision positioning system and a set of wide-area coordinates output by the wide-area positioning system are integrated in appropriate weights to obtain a set of more precise integrated coordinate. The above-mentioned intraocular pressure inspection device can prevent the intraocular pressure detection unit from failing to operate once it is not in the working area of the high-precision positioning system.

Abstract: The present embodiments relate to nucleic acid probes for detecting PTEN, ZBTB20-LSAMP, and LSAMP mutations. The nucleic acid probes are particularly useful for detecting deletions in the PTEN and LSAMP genes as diagnostics for prostate cancer, especially aggressive forms of prostate cancer for which treatment is indicated. The probes are particularly useful for in situ hybridization to chromosomes present in tissue samples.

Abstract: A detectably labeled DNA FISH probe comprises detectably-labeled nucleic acid molecules from the 8p11.23 chromosomal region and from the 2q35 chromosomal region. The probe is a FISH probe capable of detecting a fusion between the FGFR1 and FN1 genes. A patient having a disease associated with a FN1-FGFR1 gene fusion may be treated by: detecting translocation of a portion of the FGFR1 gene to the FN1 gene using chromosomal FISH probes, and treating a patient with said translocation and gene fusion with 1) a drug which inhibits FGF 2) a drug which inhibits FGFR1, and/or a 3) drug which targets a signaling pathway associated with FGFR1.

Abstract: The present invention supports a solar lamp that includes a solar panel that charges a battery to power a display panel and a processor. Based on environmental factors measured by a sensor, the processor instructs the display panel to change colors based on the value of an environmental factor. If the measured environmental factor changes values, the processor may subsequently instruct the display panel to change colors. The solar lamp may be controlled by a remote controller. The solar lamp has a receiver circuit that receives control data from the remote controller to configure the display panel. Based on the control data, a processor may instruct the display panel to change colors or change intensity. The remote controller controls a solar lamp through a wireless communications channel. Based on an indication, a processor sends control data through a wireless transmitter circuit to configure the display panel of the solar lamp.